“Bimekizumab Efficacy and Safety in Patients With Psoriatic Arthritis Who Had Skin and Nail Psoriasis at Baseline: Up to 2-year Results From Two Phase 3 Studies”, J of Skin, vol. 8, no. 6, p. s435, Nov. 2024, doi: 10.25251/skin.8.supp.435.